File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Bevacizumab-based therapy for advanced small bowel adenocarcinoma

TitleBevacizumab-based therapy for advanced small bowel adenocarcinoma
Authors
Tsang, HYau, TKhong, PLEpstein, RJ
KeywordsChemicals And Cas Registry Numbers
Issue Date2008
PublisherBMJ Publishing Group. The Journal's web site is located at http://gut.bmjjournals.com/
Citation
Gut, 2008, v. 57 n. 11, p. 1631-1632 How to Cite?
DOI: http://dx.doi.org/10.1136/gut.2008.153866
Persistent Identifierhttp://hdl.handle.net/10722/132654
ISSN
0017-5749
2023 Impact Factor: 23.0
2023 SCImago Journal Rankings: 8.052
ISI Accession Number ID
WOS:000260247000034
References
References in Scopus

 

DC FieldValueLanguage
dc.contributor.authorTsang, Hen_HK
dc.contributor.authorYau, Ten_HK
dc.contributor.authorKhong, PLen_HK
dc.contributor.authorEpstein, RJen_HK
dc.date.accessioned2011-03-28T09:27:25Z-
dc.date.available2011-03-28T09:27:25Z-
dc.date.issued2008en_HK
dc.identifier.citationGut, 2008, v. 57 n. 11, p. 1631-1632en_HK
dc.identifier.issn0017-5749en_HK
dc.identifier.urihttp://hdl.handle.net/10722/132654-
dc.languageengen_US
dc.publisherBMJ Publishing Group. The Journal's web site is located at http://gut.bmjjournals.com/en_HK
dc.relation.ispartofGuten_HK
dc.rightsGut. Copyright © BMJ Publishing Group.-
dc.subjectChemicals And Cas Registry Numbersen_US
dc.subject.meshAdenocarcinoma - drug therapyen_HK
dc.subject.meshAgeden_HK
dc.subject.meshAngiogenesis Inhibitors - therapeutic useen_HK
dc.subject.meshAntibodies, Monoclonal - therapeutic useen_HK
dc.subject.meshAntibodies, Monoclonal, Humanizeden_HK
dc.subject.meshFemaleen_HK
dc.subject.meshHumansen_HK
dc.subject.meshIntestinal Neoplasms - drug therapyen_HK
dc.subject.meshIntestine, Smallen_HK
dc.subject.meshTransforming Growth Factor beta1 - metabolismen_HK
dc.subject.meshTreatment Outcomeen_HK
dc.subject.meshVascular Endothelial Growth Factor A - metabolismen_HK
dc.titleBevacizumab-based therapy for advanced small bowel adenocarcinomaen_HK
dc.typeArticleen_HK
dc.identifier.emailYau, T: tyaucc@hku.hken_HK
dc.identifier.emailKhong, PL: plkhong@hkucc.hku.hken_HK
dc.identifier.emailEpstein, RJ: repstein@hku.hken_HK
dc.identifier.authorityYau, T=rp01466en_HK
dc.identifier.authorityKhong, PL=rp00467en_HK
dc.identifier.authorityEpstein, RJ=rp00501en_HK
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1136/gut.2008.153866en_HK
dc.identifier.pmid18941013-
dc.identifier.scopuseid_2-s2.0-54349111198en_HK
dc.identifier.hkuros146827-
dc.identifier.hkuros216918-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-54349111198&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume57en_HK
dc.identifier.issue11en_HK
dc.identifier.spage1631en_HK
dc.identifier.epage1632en_HK
dc.identifier.isiWOS:000260247000034-
dc.publisher.placeUnited Kingdomen_HK
dc.identifier.scopusauthoridTsang, H=25823417200en_HK
dc.identifier.scopusauthoridYau, T=23391533100en_HK
dc.identifier.scopusauthoridKhong, PL=7006693233en_HK
dc.identifier.scopusauthoridEpstein, RJ=34975074500en_HK
dc.identifier.issnl0017-5749-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats